INSIGHT BEHAVIORAL HEALTH CENTERS ANNOUNCES NAME CHANGE TO PATHLIGHT MOOD & ANXIETY CENTER, RENEWS COMMITMENT TO PROVIDING EXPERT, SPECIALIZED TREATMENT OF MOOD, ANXIETY AND TRAUMA-RELATED DISORDERS

NEXT STORY
My Medical Neighborhood Coalition on Health (MMNCH) Connects to GaHIN, Gaining New Interoperability Resources to Improve Patient Care
PREV STORY
Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aprea Therapeutics Presents Primary Analysis from Phase 2 Trial of Eprenetapopt + Azacitidine for Post-Transplant Maintenance Therapy in TP53 Mutant MDS and AML at the 2021 American Society of Hematology (ASH) Annual Meeting

author_avatar
NASDAQ Market News

The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year

CHICAGO and WALTHAM, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- The Foundation for Women’s ...

author_avatar
NASDAQ Market News

Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017

GAITHERSBURG, Md., May 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it ...

author_avatar
NASDAQ Market News